The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells.
about
The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The irreversible ERBB1/2/4 inh ...... to kill mammary cancer cells.
@en
The irreversible ERBB1/2/4 inh ...... to kill mammary cancer cells.
@nl
type
label
The irreversible ERBB1/2/4 inh ...... to kill mammary cancer cells.
@en
The irreversible ERBB1/2/4 inh ...... to kill mammary cancer cells.
@nl
prefLabel
The irreversible ERBB1/2/4 inh ...... to kill mammary cancer cells.
@en
The irreversible ERBB1/2/4 inh ...... to kill mammary cancer cells.
@nl
P2093
P2860
P1476
The irreversible ERBB1/2/4 inh ...... x to kill mammary cancer cells
@en
P2093
Alshad S Lalani
Andrew Poklepovic
Francesca Avogadri-Connors
Jane L Roberts
Laurence Booth
Richard E Cutler
P2860
P304
P356
10.1080/15384047.2018.1423927
P50
P577
2018-01-15T00:00:00Z